Innovation
Best Device Concepts and Technological Trends Learning Series
Innovation in Tricuspid and Pulmonic Valve Treatment
Innovation in Tricuspid and Pulmonic Valve Treatment
Episodes
Predicting Outcomes in Patients with TR Undergoing TEER Using an AI-Derived Risk Score: The EuroTR Risk Score
15 min.
Right Ventricular Reshaping Technology to Treat Patients with Functional TR (Approxima Medical)
10 min.
Versa: Technology Description and Early Human Results
10 min.
Trilio Medical: Technology Description and Experimental Results
8 min.
The CroiValve DUO Novel Tricuspid Coaptation Valve System
13 min.
The TriPair Tricuspid Repair Solution (Coramaze)
11 min.
New Generation Transcatheter Annular Repair System (Cardioband TR): Technology Update and Early EFS Results
13 min.
The Duo Sleeve System: One TAVR Access for All
11 min.
MonarQ TTVR System: Technology Update and Early Clinical Experience
10 min.
Topaz TTVR System: EFS and EU PIVOTAL Study Results
9 min.
Trisol TTVR System: EFS Update
9 min.
Laplace TTVR System: EFS Update
12 min.
Lux TTVR System: Global Clinical Experience and EFS Update
11 min.
Cardiovalve TTVR: Technology and Clinical Program Update
8 min.
Keynote Lecture: From Big to Small and Back Again: Aligning Pediatric and Adult Structural Innovation
9 min.
Synthetic Size-Adjustable Surgical Pulmonary Valve Replacement for Pediatric Patients: Autus Valve Technologies
11 min.
Expanding Valve Surgery Horizons with Personalized Leaflet Crafting: AvaTAR MedTech
11 min.
Extracellular Matrix for Tricuspid Valve Replacement: Corvivo Cardiovascular
10 min.
Polymeric Devices for Better Longevity and Performance: PECA Labs
13 min.
What’s Next for Transcatheter Tricuspid Valve Interventions – Technology and Clinical Research
19 min.
Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!
11 min.
Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!
6 min.
MonarQ System for Transcatheter Tricuspid Valve Replacement: Multicenter, First-in-Human Results
8 min.
The Topaz TTVR System: Technology for Expanded Patient Access and EFS Update
9 min.
The Trisol Medical TTVR System: US Experience
12 min.
Early Feasibility Study of the Laplace TTVR System in Patients With Severe, Symptomatic Tricuspid Regurgitation
9 min.
Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?
12 min.
TricValve: Technology and Clinical Update
13 min.
Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device
10 min.
EFS of the Edwards SAPIEN 3 THV System With the Edwards Caval Pre-Stent for the Treatment of Reverse Caval Flow in Patients With Severe TR
9 min.
Long-Term Follow Up With the DUO Coaptation Valve System for the Percutaneous Treatment of Tricuspid Regurgitation: The TANDEM I Trial
9 min.
Percutaneous Treatment of Tricuspid Regurgitation With the Novel TriFlO® Device: First in Human Italian Experience
9 min.
Orthotopic Transcatheter Tricuspid Valve Replacement: LuX-Valve Plus
17 min.
Orthotopic Transcatheter Tricuspid Valve Replacement: CardioValve
12 min.
Orthotopic Transcatheter Tricuspid Valve Replacement: Intrepid
13 min.
Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?
13 min.
New Structural Innovation: What Is Next in the Pipeline From China
11 min.
Six-Month Outcomes of the LuX-Valve Plus Transjugular Tricuspid Valve Replacement System: A Multicenter Clinical Study in High-Risk Surgical Patients
12 min.
12-Month Clinical Outcomes of K-Clip® System Transcatheter Tricuspid Annuloplasty Multicenter Pivotal Trial
16 min.